M. Hartel

559 total citations
15 papers, 390 citations indexed

About

M. Hartel is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, M. Hartel has authored 15 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in M. Hartel's work include Pancreatitis Pathology and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Gastrointestinal motility and disorders (2 papers). M. Hartel is often cited by papers focused on Pancreatitis Pathology and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Gastrointestinal motility and disorders (2 papers). M. Hartel collaborates with scholars based in Germany and Switzerland. M. Hartel's co-authors include H. P. Knaebel, Markus W. Büchler, Eduard Ryschich, Jan Schmidt, Marcus E. Martignoni, Moritz N. Wente, Helmut Friess, Markus W. Büchler, Gerhard Hoffmann and A. Richter and has published in prestigious journals such as Gut, British journal of surgery and European Journal of Cancer.

In The Last Decade

M. Hartel

14 papers receiving 382 citations

Peers

M. Hartel
M. Hartel
Citations per year, relative to M. Hartel M. Hartel (= 1×) peers Michela Bernardini

Countries citing papers authored by M. Hartel

Since Specialization
Citations

This map shows the geographic impact of M. Hartel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hartel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hartel more than expected).

Fields of papers citing papers by M. Hartel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hartel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hartel. The network helps show where M. Hartel may publish in the future.

Co-authorship network of co-authors of M. Hartel

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hartel. A scholar is included among the top collaborators of M. Hartel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hartel. M. Hartel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hartel, M., Gerhard Hoffmann, Moritz N. Wente, et al.. (2006). Randomized clinical trial of the influence of local water-filtered infrared A irradiation on wound healing after abdominal surgery. British journal of surgery. 93(8). 952–960. 71 indexed citations
2.
Hartel, M., et al.. (2005). Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut. 55(4). 519–528. 115 indexed citations
3.
Hartel, M., et al.. (2004). The role of (neo-)adjuvant therapy in rectal cancer. DMW - Deutsche Medizinische Wochenschrift. 129(17). 957–962. 1 indexed citations
4.
Ryschich, Eduard, et al.. (2004). Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. European Journal of Cancer. 40(9). 1418–1422. 163 indexed citations
5.
Mola, Fabio F. di, Pierluigi Di Sebastiano, Andrea Gardini, et al.. (2003). [Expression of connective tissue growth factor (CTGF) in pancreatic cancer].. PubMed. 89(4 Suppl). 58–9. 3 indexed citations
6.
Niedergethmann, Marco, et al.. (2001). Detektion von Mikrometastasen nach kurativer Resektion duktaler Adenokarzinome des Pankreas. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 126(11). 917–921. 2 indexed citations
7.
Bertsch, Thomas, et al.. (1997). Procalcitonin – a new marker for the acute-phase reaction in acute pancreatitis. Langenbecks Archiv für Chirurgie. 382(6). 367–367. 13 indexed citations
8.
Aufenanger, Johannes, et al.. (1997). Prokalzitonin Ein neuer Marker für die Akute-Phase-Reaktion bei akuter Pankreatitis. Langenbeck s Archives of Surgery. 382(6). 367–372. 4 indexed citations
9.
Richter, Α., et al.. (1997). Prokalzitonin. Langenbecks Archiv für Chirurgie. 382(6). 367–372. 1 indexed citations
10.
Niebergall‐Roth, Elke, Stephan Teyssen, Dawn M. Wetzel, et al.. (1997). Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy. American Journal of Physiology-Gastrointestinal and Liver Physiology. 272(6). G1550–G1559. 9 indexed citations
11.
Niebergall‐Roth, Elke, Stephan Teyssen, Dawn M. Wetzel, et al.. (1996). Comparison of the Effects of Two Cholecystokinin-Receptor Antagonists, Loxiglumide and L-364,718, on the Pancreatic Secretory Response to Intraduodenal Tryptophan in Dogs. Scandinavian Journal of Gastroenterology. 31(7). 723–732. 3 indexed citations
12.
Hartel, M., et al.. (1996). [Results of colorectal carcinoma surgery in elderly patients].. PubMed. 113. 495–8. 1 indexed citations
13.
Hartel, M., et al.. (1973). [Contrast flow rates in the superior mesenteric arterial territory].. PubMed. 118(5). 491–8. 3 indexed citations
14.
Egger, G., M. Hartel, F Halter, & Jean A. Laissue. (1971). [Nongangrenous ischemic colitis: clinical course and radiologic diagnosis].. PubMed. 115(4). 432–9.
15.
Fuchs, W. A. & M. Hartel. (1968). Die Prognose des Morbus Hodgkin auf Grund der Lymphknotenstruktur im Lymphogramm. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 109(11). 553–563. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026